Future Outlook – Recombinant Technology, Personalized Medicine, and Emerging Applications
As we look toward 2035, the IgY Polyclonal Antibodies Market is projected to reach USD 4.5 billion, growing at a CAGR of 5.9%. The future of the market will be shaped by three key trends: the adoption of recombinant technology, the expansion of personalized medicine, and the development of new therapeutic applications. The adoption of recombinant technology will enhance the...
0 Σχόλια 0 Μοιράστηκε 6 Views 0 Προεπισκόπηση